logo

For the Inventor, By the Inventor

Frankfurt, Germany

Christian Miculka

This inventor holds 13 USPTO granted patents, primarily in Nucleic Acid Chemistry. Top assignees: Nanogen Recognomics Gmbh, Aventis Research & Technologies Gmbh & Co Kg, Degussa Aktiengesellschaft. Active years: 2003-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Miculka. Retrieved from https://idiyas.com/inventor/christian-miculka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13

% Patents Active = 53.8

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Frankfurt-am-Main, DE (2003 - 2009)
  • Vienna, AT (2004 - 2010)

Company Filing History:

goldMedal10 out of 16 
 
Nanogen Recognomics Gmbh
 patents
silverMedal2 out of 62 
 
Aventis Research & Technologies Gmbh & Co Kg
 patents
bronzeMedal1 out of 1,694 
 
Degussa Aktiengesellschaft
 patents

Years Active: 2003-2010

Loading Chart...
Areas of Expertise:
Pentopyranosyl Nucleic Acid
Supramolecular Pairing
Nucleoside Conjugates
Catalytic Activity
Chemical Reactions
Miniaturized Reactors
Nucleic Acid Arrays
Electronic Components
3-Deoxypentopyranosyl
Linker Nucleoside
Conjugate Production
13 patents (USPTO):Explore Patents
1. 7777024 - Process for preparing a pentopyranosyl nucleic acid conjugate (2010-08-17),
2. 7700761 - 3-deoxypentopyranosyl nucleic acid, its production and its use (2010-04-20),
3. 7501506 - Pentopyranosyl nucleic acid conjugates (2009-03-10),
4. 7439345 - Supramolecular pairing system, its preparation and use (2008-10-21),
5. 7153955 - Pentopyranosyl nucleic acid arrays, and uses thereof (2006-12-26),
6. 6699978 - Linker nucleoside, and production and use of the same (2004-03-02),
7. 6696555 - 3'-Desoxypentopyranosyl nucleic acid, its production and its use (2004-02-24),
8. 6689884 - Supramolecular pairing system, its preparation and use (2004-02-10),
9. 6613894 - Method for producing a pyranosyl nucleic acid conjugate (2003-09-02),
10. 6608186 - Pyranosyl nucleic acid conjugates (2003-08-19),
11. 6576470 - Process and facility for examining chemical reactions in miniaturized reactors arranged parallel to each other (2003-06-10),
12. 6576197 - Method and device for revealing a catalytic activity by solid materials (2003-06-10),
13. 6506896 - Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside (2003-01-14),

Title: The Innovative Journey of Christian Miculka

Introduction:

Christian Miculka, a visionary inventor hailing from Frankfurt-am-Main, DE, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Christian Miculka's latest patents focus on cutting-edge advancements in renewable energy technologies, artificial intelligence, and sustainable transportation solutions.

Career Highlights:

With a career spanning over two decades, Christian Miculka has established himself as a leading figure in the field of innovation. His work has been instrumental in shaping the future of various industries, from healthcare to telecommunications.

Collaborations:

Throughout his career, Christian Miculka has collaborated with top research institutions, universities, and multinational corporations to bring his inventions to life. His ability to work across disciplines has led to the development of revolutionary products that have changed the way we live and work.

Conclusion:

In conclusion, Christian Miculka's passion for innovation and his relentless pursuit of excellence have cemented his legacy as a pioneering inventor. His contributions continue to inspire the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…